Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/9228
Title: Teasaponin reduces inflammation and central leptin resistance in diet-induced obese male mice
Authors: Yu, Y
Wu, Y
Wu, Z
Wang, H
Li, D
Huang, XF
Keywords: Leptin
Mice
Diet
Tea
Inflammation
Diebetes mellitus
Glucose
Metabolism
Plasma
Insulin
Issue Date: 1-Sep-2013
Publisher: Oxford University Press
Citation: Yu, Y., Wu, Y., Szabo, A., Wu, Z., Wang, H., Li, D., & Huang, X. F. (2013). Teasaponin reduces inflammation and central leptin resistance in diet-induced obese male mice. Endocrinology, 154(9), 3130-3140. doi:10.1210/en.2013-1218
Abstract: Chronic inflammation is involved in the pathogenesis of obesity and type 2 diabetes. Recently teasaponin, an extract from tea, has been shown to have antiinflammatory effects. We examined the effect of teasaponin on obesity, inflammation, glucose metabolism, and central leptin sensitivity in obese mice fed a high-fat (HF) diet for 16 weeks. Intraperitoneal injections of teasaponin (10 mg/kg, daily) for 21 days significantly decreased the food intake and body weight of HF diet-induced obese mice. Teasaponin treatment also reduced the protein levels of proinflammatory cytokines (TNF-α, IL-6, and/or IL-1β) and nuclear factor-κB signaling (phosphorylated inhibitory-κB kinase and phosphorylated inhibitory-κBα) in adipose tissue and the liver. The antiinflammatory effects of teasaponin were associated with improved glycemic status in the treated animals, evidenced by improved glucose tolerance, homeostasis model assessment, and fasting plasma insulin. In the hypothalamus, teasaponin decreased both proinflammatory cytokines and inflammatory signaling in the mediobasal hypothalamus. Teasaponin treatment also enhanced the anorexigenic effect of central leptin administration, restored leptin phosphorylated signal transducer and activator of transcription-3 (p-STAT3) signaling in the arcuate nucleus, and increased hypothalamic expression of the anorexigenic peptide proopiomelanocortin. These results identify a potential novel application for teasaponin as an antiobesity and antiinflammatory agent. © 2013, Oxford University Press
Gov't Doc #: 8909
URI: https://doi.org/10.1210/en.2013-1218
http://apo.ansto.gov.au/dspace/handle/10238/9228
ISSN: 1945-7170
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.